Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

4MBS

Crystal Structure of the CCR5 Chemokine Receptor

Summary for 4MBS
Entry DOI10.2210/pdb4mbs/pdb
DescriptorChimera protein of C-C chemokine receptor type 5 and Rubredoxin, 4,4-difluoro-N-[(1S)-3-{(3-exo)-3-[3-methyl-5-(propan-2-yl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]oct-8-yl}-1-phenylpropyl]cyclohexanecarboxamide, ZINC ION, ... (5 entities in total)
Functional Keywordshuman ccr5 chemokine receptor, anti-hiv agent, novel protein engineering, gpcr network, membrane protein, psi-biology, structural genomics, seven transmembrane helices, g protein-coupled receptor, membrane, signaling protein
Biological sourceHomo sapiens
More
Cellular locationCell membrane ; Multi-pass membrane protein : P51681
Total number of polymer chains2
Total formula weight99756.11
Authors
Tan, Q.,Zhu, Y.,Han, G.W.,Li, J.,Fenalti, G.,Liu, H.,Cherezov, V.,Stevens, R.C.,GPCR Network (GPCR),Zhao, Q.,Wu, B. (deposition date: 2013-08-19, release date: 2013-09-11, Last modification date: 2023-09-20)
Primary citationTan, Q.,Zhu, Y.,Li, J.,Chen, Z.,Han, G.W.,Kufareva, I.,Li, T.,Ma, L.,Fenalti, G.,Li, J.,Zhang, W.,Xie, X.,Yang, H.,Jiang, H.,Cherezov, V.,Liu, H.,Stevens, R.C.,Zhao, Q.,Wu, B.
Structure of the CCR5 chemokine receptor-HIV entry inhibitor maraviroc complex.
Science, 341:1387-1390, 2013
Cited by
PubMed Abstract: The CCR5 chemokine receptor acts as a co-receptor for HIV-1 viral entry. Here we report the 2.7 angstrom-resolution crystal structure of human CCR5 bound to the marketed HIV drug maraviroc. The structure reveals a ligand-binding site that is distinct from the proposed major recognition sites for chemokines and the viral glycoprotein gp120, providing insights into the mechanism of allosteric inhibition of chemokine signaling and viral entry. A comparison between CCR5 and CXCR4 crystal structures, along with models of co-receptor-gp120-V3 complexes, suggests that different charge distributions and steric hindrances caused by residue substitutions may be major determinants of HIV-1 co-receptor selectivity. These high-resolution insights into CCR5 can enable structure-based drug discovery for the treatment of HIV-1 infection.
PubMed: 24030490
DOI: 10.1126/science.1241475
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.71 Å)
Structure validation

227111

数据于2024-11-06公开中

PDB statisticsPDBj update infoContact PDBjnumon